Secondary Logo

Published Ahead-of-Print - Last Updated: January 09, 2019

The editors of this journal are pleased to offer electronic publication of accepted papers prior to print publication. These papers can be cited using the date of access and the unique DOI number. Any final changes in manuscripts will be made at the time of print publication and will be reflected in the final electronic version of the issue.

Disclaimer: Articles appearing in this Published Ahead-of-Print section have been peer-reviewed and accepted for publication in this journal and posted online before print publication. Articles appearing here may contain statements, opinions, and information that have errors in facts, figures, or interpretation. Accordingly, Lippincott Williams & Wilkins, the editors and authors and their respective employees are not responsible or liable for the use of any such inaccurate or misleading data, opinion or information contained in the articles in this section.

Published Ahead-of-Print Articles are available in PDF format only.

PDF Only

Short communication: rapid quantitation of flecainide in human plasma for therapeutic drug monitoring using liquid chromatography and time-of-flight mass-spectrometry.

Rahman, Mohammed; Couchman, Lewis; Povstyan, Valentyna; More

Therapeutic Drug Monitoring. ., Post Acceptance: December 04, 2018

PDF Only

Discrimination of anti-drug antibodies with neutralizing capacity in infliximab and adalimumab treated patients: Comparison of the homogeneous mobility shift assay and the affinity capture and elution assay.

Hock, Barry D.; McKenzie, Judith L.; Goddard, Liping; More

Therapeutic Drug Monitoring. ., Post Acceptance: December 27, 2018

Absence of relationship between CDAI or CRP and infliximab exposure calls for objective Crohn’s disease activity measures for the evaluation of treatment effects at treatment failure

Edlund, Helena; Grisic, Ana-Marija; Steenholdt, Casper; More

Therapeutic Drug Monitoring. ., Post Acceptance: December 26, 2018

PDF Only

PDF Only